139 related articles for article (PubMed ID: 22457930)
1. Semisyngeneic hybrid resistance to murine teratocarcinoma cells.
Bishop GA; Dove WF
Immunogenetics; 1980; 10(4):383-93. PubMed ID: 22457930
[TBL] [Abstract][Full Text] [Related]
2. The genetics of teratocarcinoma transplantation: tumor formation in allogeneic hosts by the embryonal carcinoma cell lines F9 and PCC3.
Avner PR; Dove WF; Dubois P; Gaillard JA; Guénet JL; Jacob F; Jakob H; Shedlovsky A
Immunogenetics; 1978 Dec; 7(1):103-15. PubMed ID: 21302063
[TBL] [Abstract][Full Text] [Related]
3. Genetics of teratocarcinoma transplantation. III. Genetic control of resistance to F9 tumor formation in allogeneic hosts.
Avner P; Simmler MC
J Reprod Immunol; 1982 Feb; 4(1):31-7. PubMed ID: 7069666
[TBL] [Abstract][Full Text] [Related]
4. Genetics of teratocarcinoma transplantation. II. Effect of a semidominant H-2-linked gene lying outside the immediate major histocompatibility complex on tumor formation by the embryonal carcinoma cell line F9 in H-2 congenic pairs.
Avner P
Transplantation; 1980 Sep; 30(3):185-90. PubMed ID: 14582174
[TBL] [Abstract][Full Text] [Related]
5. Genetic mapping of the embryonal carcinoma transplantation resistance locus Gt(B6) to mouse Chromosome 8.
Muller AJ; Heiden KB; Teresky AK; Levine AJ
Immunogenetics; 1999 Oct; 49(11-12):949-56. PubMed ID: 10501837
[TBL] [Abstract][Full Text] [Related]
6. H-2 antigen expression on teratocarcinoma cells passaged in genetically resistant mice is regulated by lymphoid cells.
Ostrand-Rosenberg S; Cohn A
Proc Natl Acad Sci U S A; 1981 Nov; 78(11):7106-10. PubMed ID: 7031669
[TBL] [Abstract][Full Text] [Related]
7. T-cell-mediated cytotoxic immune responses to F9 teratocarcinoma cells: cytolytic effector T cells lyse H-2-negative F9 cells and syngeneic spermatogonia.
Wagner H; Starzinski-Powitz A; Röllinghoff M; Golstein P; Jakob H
J Exp Med; 1978 Jan; 147(1):251-64. PubMed ID: 415107
[TBL] [Abstract][Full Text] [Related]
8. Embryonal carcinoma cells (and their somatic cell hybrids) are resistant to infection by the murine parvovirus MVM, which does infect other teratocarcinoma-derived cell lines.
Miller RA; Ward DC; Ruddle FH
J Cell Physiol; 1977 Jun; 91(3):393-401. PubMed ID: 558990
[TBL] [Abstract][Full Text] [Related]
9. Hybrids between F9 nullipotent teratocarcinoma and thymus cells produce multidifferentiated tumors in mice.
Rousset JP; Bucchini D; Jami J
Dev Biol; 1983 Apr; 96(2):331-6. PubMed ID: 6832476
[TBL] [Abstract][Full Text] [Related]
10. The unique killing of embryo-derived teratocarcinoma cells by nonactivated murine macrophages is not due to a lack of H-2 antigen expression.
Sionov RV; Gallily R
Cell Immunol; 1992 Jul; 142(2):416-25. PubMed ID: 1623557
[TBL] [Abstract][Full Text] [Related]
11. Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major.
Mitchell GF
J Immunogenet; 1983 Oct; 10(5):395-412. PubMed ID: 6606002
[TBL] [Abstract][Full Text] [Related]
12. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
Martin GM; Ogburn CE; Au K; Disteche CM
J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
[TBL] [Abstract][Full Text] [Related]
13. Involvement of NK1+ CD4- CD8- alphabeta T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice.
Nakamura E; Kubota H; Sato M; Sugie T; Yoshida O; Minato N
J Immunol; 1997 Jun; 158(11):5338-48. PubMed ID: 9164954
[TBL] [Abstract][Full Text] [Related]
14. Expression of the teratocarcinoma phenotype in hybrids between totipotent mouse teratocarcinoma and myeloma cells.
Correani A; Croce CM
J Cell Physiol; 1980 Oct; 105(1):73-9. PubMed ID: 7430268
[TBL] [Abstract][Full Text] [Related]
15. Expression of hybrid Ia molecules on the cell surface of reticulum cell sarcomas that are undetectable on host SJL/J lymphocytes.
Wilbur SM; Bonavida B
J Exp Med; 1981 Mar; 153(3):501-13. PubMed ID: 6166700
[TBL] [Abstract][Full Text] [Related]
16. Properties of teratocarcinoma-thymus somatic cell hybrids.
Miller RA; Ruddle FH
Somatic Cell Genet; 1977 May; 3(3):247-61. PubMed ID: 605385
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of allogeneic mice to teratocarcinoma 402AX.
Ostrand-Rosenberg S; Rider TM; Twarowski A
Immunogenetics; 1980; 10(6):607-12. PubMed ID: 22457940
[No Abstract] [Full Text] [Related]
18. H-2 class I antigen expression on mouse teratocarcinoma cell lines.
Démant P; Oudshoorn-Snoek M
Immunogenetics; 1985; 22(6):543-52. PubMed ID: 4077148
[TBL] [Abstract][Full Text] [Related]
19. Embryo-derived teratocarcinoma. III. Development of tumors from teratocarcinoma-permissive and non-permissive strain embryos transplanted to F1 hybrids.
Solter D; Dominis M; Damjanov I
Int J Cancer; 1981 Oct; 28(4):479-83. PubMed ID: 7309292
[TBL] [Abstract][Full Text] [Related]
20. [Hybrids between F9 "nullipotent" teratocarcinoma and rat thymus cells produce differentiated cells].
Hsu WM; Song QB; Yao Z
Shi Yan Sheng Wu Xue Bao; 1985 Jun; 18(2):177-87. PubMed ID: 3835750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
